| Literature DB >> 27862579 |
Leslie Matalonga1, Miren Bravo1, Carla Serra-Peinado2, Elisabeth García-Pelegrí1, Olatz Ugarteburu1, Silvia Vidal1, Maria Llambrich1, Ester Quintana1, Pedro Fuster-Jorge3, Maria Nieves Gonzalez-Bravo3, Sergi Beltran4,5, Joaquin Dopazo6, Francisco Garcia-Garcia6, François Foulquier7, Gert Matthijs8, Philippa Mills9, Antonia Ribes1, Gustavo Egea2, Paz Briones1, Frederic Tort1, Marisa Girós1.
Abstract
Congenital disorders of glycosylation (CDG) are a heterogeneous and rapidly growing group of diseases caused by abnormal glycosylation of proteins and/or lipids. Mutations in genes involved in the homeostasis of the endoplasmic reticulum (ER), the Golgi apparatus (GA), and the vesicular trafficking from the ER to the ER-Golgi intermediate compartment (ERGIC) have been found to be associated with CDG. Here, we report a patient with defects in both N- and O-glycosylation combined with a delayed vesicular transport in the GA due to mutations in TRAPPC11, a subunit of the TRAPPIII complex. TRAPPIII is implicated in the anterograde transport from the ER to the ERGIC as well as in the vesicle export from the GA. This report expands the spectrum of genetic alterations associated with CDG, providing new insights for the diagnosis and the understanding of the physiopathological mechanisms underlying glycosylation disorders.Entities:
Keywords: CDG; Golgi; TRAPPC11; endoplasmic reticulum; vesicle trafficking
Mesh:
Substances:
Year: 2016 PMID: 27862579 DOI: 10.1002/humu.23145
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878